Verano Holdings Corp. (VRNO): Results of Operations and Financial Condition
Verano Holdings Corp. (VRNO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 vrno-2026630xexx991.htm EX-99.1 Document Verano Announces Strong Second Quarter 2026 Financial Results Highlighted by $218 Million in Revenue Company delivers third consecutive quarter of revenue gains and improved cash flow from operations driven by organic growth CHIC
How this was made
The 30-second read
Why it matters
Traders can update models using the newly reported revenue, EBITDA, operating cash flow, and the tightened 2026 capex range. The rescheduling confirmation and state expansion items may also influence sentiment, but the quantified financials and guidance are the primary decision inputs.
Market read
Fresh quarterly financials plus a capex guidance tightening can drive near-term repricing, especially for investors focused on cash generation and growth funding needs.
What to watch
The 1-for-5 reverse split and relatively modest $2M repurchase authorization may not materially change fundamentals; investors may instead scrutinize leverage ($393M net debt) and the credibility of capex-to-growth execution.
Background
This is Verano’s SEC Form 8-K (Item 2.02) releasing Q2 2026 financial results and related operational updates, including capital allocation and guidance.
Ticker impact
Verano reports Q2 2026 results with $218M revenue, $51M adjusted EBITDA, $31M operating cash flow, and tightens 2026 capex guidance to $40M-$50M.
Likely supportive for the stock on any earnings-day reaction, with follow-through dependent on whether investors focus on revenue growth, cash flow improvement, or margin compression.
The article is a primary SEC 8-K with quantified results and guidance. It also includes a reverse split and a small buyback authorization, but the most decision-relevant items are the new financials and the capex range update.
Market effects
Adds incremental evidence on multi-state cannabis operators’ ability to grow revenue and improve operating cash flow, while highlighting ongoing margin pressure.
Florida retail expansion and Virginia adult-use rollout timing reinforce state-by-state demand ramp expectations for operators with similar footprints.
Limited direct global spillover, but contributes to the broader US cannabis policy narrative around rescheduling and market access.
Counterpoint
Despite revenue growth, gross margin fell vs the prior-year quarter and the company still reports net losses, so the equity may remain valuation-constrained.
Key entities
- companyVerano Holdings Corp.
Multi-state cannabis operator reporting Q2 2026 results, operating cash flow, and updated 2026 capex guidance.
- regulatorU.S. Drug Enforcement Administration (DEA)
Applications submitted to register certain state-licensed medical cannabis operations.
- executiveGeorge Archos
Founder, Chairman and CEO providing commentary on results and capital markets engagement.